clinical trial · NCT01524276
Product Surveillance Registry
Medtronic·—·recruiting·n = 100,000
Cardiac Rhythm DisordersUrological DisordersNeurological DisordersCardiovascular DisordersDigestive DisordersIntracranial AneurysmMechanical Circulatory SupportRespiratory Therapy
brief summary
The purpose of the Registry is to provide continuing evaluation and periodic reporting of safety and effectiveness of Medtronic market-released products. The Registry data is intended to benefit and support interests of patients, hospitals, clinicians, regulatory bodies, payers, and industry by streamlining the clinical surveillance process and facilitating leading edge performance assessment via the least burdensome approach.
started
Jan 1, 2012
primary completion
Jan 1, 2040
completion
Jan 1, 2040
last updated
Apr 21, 2026
official title
Medtronic Product Surveillance Registry
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol